-
Novartis, AbbVie Face Legal Defeat Over 340B Contract Pharmacies
Wednesday, September 24, 2025 - 1:52pm | 634Read More...A U.S. federal judge has rejected challenges by two pharmaceutical manufacturers seeking to block a Maine law that regulates the use of contract pharmacies under the federal 340B drug discount program. Novartis AG (NYSE:NVS) and AbbVie Inc. (NYSE:ABBV) argued the statute conflicted with federal law...


